Ảnh Hưởng Tiêu Cực của Nhiệt Độ Tăng Cao Đến Cấu Trúc và Hoạt Động của Hỗn Hợp Phenylalanine Ammonia Lyase-Bovine Serum Albumin và Tiềm Năng Ổn Định của Chất Tensioactif và Đường

Blau N, van Spronsen FJ, Levy HL. Phenylketonuria Lancet. 2010;376(9750):1417–27. Feillet F, van Spronsen FJ, MacDonald A, Trefz FK, Demirkol M, Giovannini M, et al. Challenges and pitfalls in the management of phenylketonuria. Pediatrics. 2010;126(2):333–41. Scriver CR. The PAH gene, phenylketonuria, and a paradigm shift. Hum Mutat. 2007;28(9):831–45. Vockley J, Andersson HC, Antshel KM, Braverman NE, Burton BK, Frazier DM, et al. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med. 2014;16(2):188–200. MacDonald A, Gokmen-Ozel H, van Rijn M, Burgard P. The reality of dietary compliance in the management of phenylketonuria. J Inherit Metab Dis. 2010;33(6):665–70. Trefz FK, Belanger-Quintana A. Sapropterin dihydrochloride: a new drug and a new concept in the management of phenylketonuria. Drugs of today. 2010;46(8):589–600. Hydery T, Coppenrath VA. A Comprehensive review of pegvaliase, an enzyme substitution therapy for the treatment of phenylketonuria. Drug Target Insights. 2019;13:1177392819857089. MacDonald MJ, D'Cunha GB. A modern view of phenylalanine ammonia lyase. Biochemistry and cell biology = Biochimie et biologie cellulaire. 2007;85(3):273–82. Mahan KC, Gandhi MA, Anand S. Pegvaliase: a novel treatment option for adults with phenylketonuria. Curr Med Res Opin. 2019;35(4):647–51. Besada C, Hakami A, Pillai G, Yetsko K, Truong N, Little T, et al. Preformulation studies with phenylalanine ammonia lyase: essential prelude to a microcapsule formulation for the management of phenylketonuria. J Pharm Sci. 2022;111(7):1857–67. Putney SD, Burke PA. Improving protein therapeutics with sustained-release formulations. Nat Biotechnol. 1998;16(2):153–7. Tahara Y, Kamiya N, Goto M. Solid-in-oil dispersion: a novel core technology for drug delivery systems. Int J Pharm. 2012;438(1–2):249–57. Ameri M, Maa Y-F. Spray drying of biopharmaceuticals: stability and process considerations. Drying Technol. 2006;24:763–8. Pinto J.T FE, Dieplinger J,Dekner M, Makert C, Nieder M, Paudel A. Progress in spray-drying of protein pharmaceuticals: literature analysis of trends in formulation and process attributes. Drying Technology. 2021;39(11):1415–46. Habibi-Moini S, D’Mello AP. Evaluation of possible reasons for the low phenylalanine ammonia lyase activity in cellulose nitrate membrane microcapsules. Int J Pharm. 2001;215(1–2):185–96. Cui JD, Li LL, Bian HJ. Immobilization of cross-linked phenylalanine ammonia lyase aggregates in microporous silica gel. PLoS ONE. 2013;8(11): e80581. Cui Jd, Ll C, Sp Z, Zhang Yf Su, Zg MG. Hybrid magnetic cross-linked enzyme aggregates of phenylalanine ammonia lyase from Rhodotorula glutinis. PLoS ONE. 2014;9(5): e97221. Cui J, Liang L, Han C. Stabilization of phenylalanine ammonia lyase from Rhodotorula glutinis by encapsulation in polyethyleneimine-mediated biomimetic silica. Appl Biochem Biotechnol. 2015;176(4):999–1011. Rees GD, Jones HD. Stability of l-phenylalanine ammonia-lyase in aqueous solution and as the solid state in air and organic solvents. Enzyme Microb Technol. 1996;19(4):282–8. Good NE, Izawa S. Hydrogen ion buffers. Methods Enzymol. 1972;24:53–68. Kovacs K, Banoczi G, Varga A, Szabo I, Holczinger A, Hornyanszky G, et al. Expression and properties of the highly alkalophilic phenylalanine ammonia-lyase of thermophilic Rubrobacter xylanophilus. PLoS ONE. 2014;9(1): e85943. Calabrese JC, Jordan DB, Boodhoo A, Sariaslani S, Vannelli T. Crystal structure of phenylalanine ammonia lyase: multiple helix dipoles implicated in catalysis. Biochemistry. 2004;43(36):11403–16. Woody RW. Circular dichroism. Methods Enzymol. 1995;246:34–71. Marini I, Moschini R, Del Corso A, Mura U. Chaperone-like features of bovine serum albumin: a comparison with α-crystallin. Cellular and Molecular Life Sciences CMLS. 2005;62(24):3092–9. Finn TE, Nunez AC, Sunde M, Easterbrook-Smith SB. Serum albumin prevents protein aggregation and amyloid formation and retains chaperone-like activity in the presence of physiological ligands. J Biol Chem. 2012;287(25):21530–40. Takeda K, Wada A, Yamamoto K, Moriyama Y, Aoki K. Conformational change of bovine serum albumin by heat treatment. J Protein Chem. 1989;8(5):653–9. Moriyama Y, Kawasaka Y, Takeda K. Protective effect of small amounts of sodium dodecyl sulfate on the helical structure of bovine serum albumin in thermal denaturation. J Colloid Interface Sci. 2003;257(1):41–6. Lin VJ, Koenig JL. Raman studies of bovine serum albumin. Biopolymers. 1976;15(1):203–18. Bischof JC, He X. Thermal stability of proteins. Ann N Y Acad Sci. 2006;1066(1):12–33. Bian H, Zhang H, Yu Q, Chen Z, Liang H. Studies on the interaction of cinnamic acid with bovine serum albumin. Chem Pharm Bull. 2007;55(6):871–5. Singh TS, Mitra S. Interaction of cinnamic acid derivatives with serum albumins: a fluorescence spectroscopic study. Spectrochim Acta Part A Mol Biomol Spectrosc. 2011;78(3):942–8. Nunes NM, Pacheco AFC, Agudelo AJP, da Silva LHM, Pinto MS, Hespanhol MDC, et al. Interaction of cinnamic acid and methyl cinnamate with bovine serum albumin: a thermodynamic approach. Food Chem. 2017;237:525–31. Paul BK, Samanta A, Guchhait N. Exploring hydrophobic subdomain IIA of the protein bovine serum albumin in the native, intermediate, unfolded, and refolded states by a small fluorescence molecular reporter. J Phys Chem B. 2010;114(18):6183–96. Tong JHT, Qin A, Sun JZ, Tang BZ. Deciphering the binding behaviours of BSA using ionic AIE-active fluorescent probes. Faraday Discuss. 2017;196:285–303. Khatun S, Riyazuddeen, Yasmeena,S., Kumar, A., Subbarao,N. Calorimetric, spectroscopic and molecular modelling insight into the interaction of gallic acid with bovine serum albumin. The Journal of Chemical Thermodynamics. 2018;122:85 -94. Precupas A, Sandu R, Popa VT. Quercetin influence on thermal denaturation of bovine serum albumin. J Phys Chem B. 2016;120(35):9362–75. Sułkowska A, Maciążek M, Równicka J, Bojko B, Pentak D, Sułkowski WW. Effect of temperature on the methotrexate BSA interaction: spectroscopic study. J Mol Struct. 2007;834:162–9. Roy AS, Pandey NK, Dasgupta S. Preferential binding of fisetin to the native state of bovine serum albumin: spectroscopic and docking studies. Mol Biol Rep. 2013;40(4):3239–53. Brown JR. Albumin: structure, function, and uses. Pergamon Press. 1977;Rosenoer, V.M., Oraz, M., and Rotshild, M.A. Eds:27. Kamerzell TJ, Esfandiary R, Joshi SB, Middaugh CR, Volkin DB. Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development. Adv Drug Deliv Rev. 2011;63(13):1118–59. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544–75. Otzen D. Protein-surfactant interactions: a tale of many states. Biochem Biophys Acta. 2011;1814(5):562–91. Moriyama Y, Takeda K. Re-formation of the helical structure of human serum albumin by the addition of small amounts of sodium dodecyl sulfate after the disruption of the structure by urea. A comparison with bovine serum albumin. Langmuir. 1999;15(6):2003–8. Moriyama Y, Watanabe E, Kobayashi K, Harano H, Inui E, Takeda K. Secondary structural change of bovine serum albumin in thermal denaturation up to 130 C and protective effect of sodium dodecyl sulfate on the change. J Phys Chem B. 2008;112(51):16585–9. Baier S, McClements DJ. Impact of preferential interactions on thermal stability and gelation of bovine serum albumin in aqueous sucrose solutions. J Agric Food Chem. 2001;49(5):2600–8. Panzica M, Emanuele A, Cordone L. Thermal aggregation of bovine serum albumin in trehalose and sucrose aqueous solutions. J Phys Chem B. 2012;116(39):11829–36. Shil S, Das N, Sengupta B, Sen P. Sucrose-induced stabilization of domain-ii and overall human serum albumin against chemical and thermal denaturation. ACS Omega. 2018;3(12):16633–42. Barreca D, Lagana G, Ficarra S, Tellone E, Leuzzi U, Magazu S, et al. Anti-aggregation properties of trehalose on heat-induced secondary structure and conformation changes of bovine serum albumin. Biophys Chem. 2010;147(3):146–52. Hedoux A, Willart JF, Paccou L, Guinet Y, Affouard F, Lerbret A, et al. Thermostabilization mechanism of bovine serum albumin by trehalose. J Phys Chem B. 2009;113(17):6119–26. Lavecchia Roberto ZA. Effect of trehalose on thermal stability of bovine serum albumin. Chem Lett. 2010;39:38–9. Back JF, Oakenfull D, Smith MB. Increased thermal stability of proteins in the presence of sugars and polyols. Biochemistry. 1979;18(23):5191–6. Kaushik JK, Bhat R. Why is trehalose an exceptional protein stabilizer? An analysis of the thermal stability of proteins in the presence of the compatible osmolyte trehalose. J Biol Chem. 2003;278(29):26458–65. Lee JC, Timasheff SN. The stabilization of proteins by sucrose. J Biol Chem. 1981;256(14):7193–201. Arakawa T, Kita Y, Carpenter JF. Protein–solvent interactions in pharmaceutical formulations. Pharm Res. 1991;8(3):285–91. Arakawa T, Timasheff SN. Stabilization of protein structure by sugars. Biochemistry. 1982;21(25):6536–44. Liu Y, Bolen DW. The peptide backbone plays a dominant role in protein stabilization by naturally occurring osmolytes. Biochemistry. 1995;34(39):12884–91. Chang LL, Pikal MJ. Mechanisms of protein stabilization in the solid state. J Pharm Sci. 2009;98(9):2886–908. Mensink MA, Frijlink HW, van der Voort MK, Hinrichs WL. How sugars protect proteins in the solid state and during drying (review): mechanisms of stabilization in relation to stress conditions. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV. 2017;114:288–95. Jones LS, Randolph TW, Kohnert U, Papadimitriou A, Winter G, Hagmann ML, et al. The effects of Tween 20 and sucrose on the stability of anti-L-selectin during lyophilization and reconstitution. J Pharm Sci. 2001;90(10):1466–77. Zhang MZ, Pikal K, Nguyen T, Arakawa T, Prestrelski SJ. The effect of the reconstitution medium on aggregation of lyophilized recombinant interleukin-2 and ribonuclease A. Pharm Res. 1996;13(4):643–6. Arakawa T, Prestrelski SJ, Kenney WC, Carpenter JF. Factors affecting short-term and long-term stabilities of proteins. Adv Drug Deliv Rev. 2001;46(1–3):307–26. Allison SD, Chang B, Randolph TW, Carpenter JF. Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding. Arch Biochem Biophys. 1999;365(2):289–98. Schebor C, Mazzobre MF, Buera MP. Glass transition and time-dependent crystallization behavior of dehydration bioprotectant sugars. Carbohydr Res. 2010;345(2):303–8. Yadav JK, Prakash V. Thermal stability of α-amylase in aqueous cosolvent systems. J Biosci. 2009;34(3):377–87. Miroliaei M, Ranjbar B, Naderi-Manesh H, Nemat-Gorgani M. Thermal denaturation of yeast alcohol dehydrogenase and protection of secondary and tertiary structural changes by sugars: CD and fluorescence studies. Enzyme Microb Technol. 2007;40(4):896–901. Lee J, Ko JH, Lin EW, Wallace P, Ruch F, Maynard HD. Trehalose hydrogels for stabilization of enzymes to heat. Polym Chem. 2015;6(18):3443–8. Sola-Penna M, Meyer-Fernandes JR. Stabilization against thermal inactivation promoted by sugars on enzyme structure and function: why is trehalose more effective than other sugars? Arch Biochem Biophys. 1998;360(1):10–4.